CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-27 | Kramer Robert EVP, Administration and CFO | Grant or award · Employee Stock Option (right to buy) | +23,670 | $49.64 | $1.2M | 23,670 |
| 2018-02-27 | Havey Adam EVP, Business Operations | Grant or award | +5,036 | 31,082 | ||
| 2018-02-27 | Havey Adam EVP, Business Operations | Grant or award | +5,036 | 36,118 | ||
| 2018-02-27 | Havey Adam EVP, Business Operations | Shares withheld for taxes | −409 | $49.64 | $20K | 35,709 |
| 2018-02-27 | Havey Adam EVP, Business Operations | Grant or award · Employee Stock Option (right to buy | +20,145 | $49.64 | $1000K | 20,145 |
| 2018-02-27 | Abdun-Nabi Daniel President & CEO | Grant or award | +13,371 | 217,505 | ||
| 2018-02-27 | Abdun-Nabi Daniel President & CEO | Grant or award | +13,371 | 230,876 | ||
| 2018-02-27 | Abdun-Nabi Daniel President & CEO | Shares withheld for taxes | −3,324 | $49.64 | $165K | 227,552 |
| 2018-02-27 | Abdun-Nabi Daniel President & CEO | Grant or award · Employee Stock Option (right to buy) | +53,485 | $49.64 | $2.7M | 53,485 |
| 2018-02-27 | El-Hibri Fuad Chairman | Exercise or conversion | +9,794 | 1,540,010 | ||
| 2018-02-27 | El-Hibri Fuad Chairman | Shares withheld for taxes | −2,385 | $49.64 | $118K | 1,537,625 |
| 2018-02-27 | El-Hibri Fuad Chairman | Grant or award · Restrictive Stock Units | +19,288 | 81,352 | ||
| 2018-02-27 | El-Hibri Fuad Chairman | Grant or award · Employee Stock Options (Right to Buy) | +38,577 | 38,577 | ||
| 2018-02-27 | El-Hibri Fuad Chairman | Exercise or conversion · Restrictive Stock Units | −9,794 | 71,558 | ||
| 2018-01-23 | Hauer Jerome M Director | Sale | −2,577 | $50.25 | $129K | 16,068 |
| 2018-01-22 | Hauer Jerome M Director | Exercise or conversion | +5,152 | $25.47 | $131K | 23,797 |
| 2018-01-22 | Hauer Jerome M Director | Sale | −5,152 | $50.91 | $262K | 18,645 |
| 2018-01-22 | Hauer Jerome M Director | Exercise or conversion · Stock Option (Right to Buy) | −5,152 | 0 | ||
| 2018-01-02 | Abdun-Nabi Daniel President & CEO | Exercise or conversion | +21,906 | $14.44 | $316K | 226,040 |
| 2018-01-02 | Abdun-Nabi Daniel President & CEO | Sale | −21,906 | $47.91 | $1.0M | 204,134 |
Page 41 of 45 · 887 trades